Cao Honghui, current Deputy Director General of China Development Bank’s Research & Development Department and CBD’s Center for Financial Research & Development, senior expert, a professor and PhD Supervisor of Graduate School of Chinese Academy of Social Sciences, specializes in financial market, macroeconomics, payment and settlement, researches about international strategies and investment management for a long time. During his time in CDB, he hosted strategic researches on areas covering Southeast Asia, Central Asia, South Asia, Oceania and Latin America, and set cross-boundary business plans for China’s peripheral areas within Asia. He participated in researches of various major projects including “Connectivity and Cooperation within Asia” and “One Belt and One Road Strategy”, aiming at establishing a series of major projects in China’s peripheral areas within Asia covering transportation, energy, telecommunication and industrial park.
He served as a member of China International Financial Consulting Commission, a member of China Standing Committee for Pacific Economic Cooperation Council, an expert for eastern Asian Finance Cooperation, a financial consultant for APEC and World Bank, an advisory for United Nations Development Programme, a consultant for VISA and an industrial expert to China UnionPay, and assumed roles in several companies as independent chairman. He hosted a series of major subject researches at home and abroad. Besides, he took part in expert meetings held by Central Committee, and provided advice and consultations on a variety of major issues, as a host or participant, including Reform of RMB Exchange Rate Formation Mechanism, Strategy for RMB Internationalization, Capital Market Reform and Development Plan, Asset Securitization Pilot Plan, Banking Industry Reform Plan, Global Governance Report by United Nations, Progress Report of Financial Cooperation among East Asia, Performance Report of APEC Meeting of Financial Ministers, etc.
Michael Hua is the Head of New Business Development at Johnson & Johnson Medical China. He has a corporate growth strategy consulting and M&A background both inside and outside China. Since joining Johnson & Johnson, he has been involved in a number of major medical device transactions including the Synthes acquisition.
Dr. Yong Huang is the Director of the Competition Law Centre of the University of International Business and Economics (UIBE) and law Professor of UIBE Law School. Currently, he is also appointed as a member of the Expert Advisory Board of the State Council Anti-Monopoly Commission and Chief Researcher of the Supreme People's Court Judicial Cases Research Institute.
Professor Huang has been entrusted by a variety of Chinese government agencies, legislative bodies and international organizations to conduct research projects in relation to competition law issues. These instructions come from: Legislative Affairs Office of the State Council, Ministry of Commerce, State Administration of Industry and Commerce, National Development and Reform Commission, Ministry of Justice, National People’s Congress, EU-China Trade Project and Asian Development Bank, etc.
Dr.Chao Chen is the Head of the Research Department at China Investment Corporation. He graduated from Tsinghua University with Ph.D. in economics and an MFE at the University of Oxford. He started his career at the People’s Bank of China and was involved in the establishment of Central Huijin Corporation, which is the largest shareholder of major Chinese strategic financial institutions. He then joined CIC since its conception and later joined ICBC Credit Suisse Asset Management Corporation as Chief Economist and CIO in 2009. By the end of 2012, he returned to CIC as Head of European Private Equity Investment and moved to the Research Department by the end of 2016. He is a lecturer at several Chinese leading universities and is a prolific writer and has published almost 100 academic articles and five books in economics and finance.
Mr. Weng serves as Executive Vice President & Managing Director at China Financial International Investments Ltd. He brings over ten years of global finance and investing experience.
Mr. Weng previously served as Director of M&A and Strategic Investments at China Vanke, as well as Investment Director at Mackenzie Investments in Canada. Furthermore, Mr. Weng worked at global institutional investors including China Life Asset Management, UBS, and D. E. Shaw.
Mr. Weng received his MBA from Harvard Business School and his Bachelor in Economics from Yale University. In addition, Mr. Weng is a CFA and FRM charterholder.
Outside of work, Mr. Weng taught at Harvard University, Harvard Business School and the University of Toronto Rotman School of Management. He is also an active member of Harvard and Yale alumni associations.
Mr Lu Changqi is the founder of Ample Harvest Finance and holds the positions of its board member and Chairman of its Investment Committee.
Prior to Ample Harvest, Mr. Lu worked for the joint venture of Hewlett Packard, an American enterprise and later worked as a senior manager for the joint venture of MARTA, a French enterprise. In 1996, he established a joint venture with the Shanghai Municipal Government to reengage in IT businesses and related fields. He has successfully participated in the investment and launching of a number of Chinese companies listed in the A-share market, the H-share market and the NYSE.
Mr Lu graduated from Fudan University with a Master of Science degree and was appointed as the Director of Fudan University in 2015.
Mr. Jason Zhao is the founding Managing Partner of CGF Capital Management and Founding member/Senior Advisor of China Post Life’s Alternative Investment Group. Jason focuses on Technology and Financial Services investments, and is experienced in cross border M&A, technology transfer and localisation, and specialises in bridging western management and market resources with Chinese companies. Jason also serves as an investment committee member and venture partner of several Chinese government and multinational company Chinese investment funds. He is frequently invited by the central government and national trade organizations to advise in market research and new policy discussions and drafting.
Prior to his investment career, Jason worked in US, Chinese and European multinational corporations such as Motorola, Sinopec, and Marconi, etc., and has held many senior management positions in functions ranging from product management, marketing to engineering. Jason hold MS and BS degrees in Engineering from US and Chinese universities and an MBA from the University of Chicago.
Yiqing Wang is China Editor of Mergermarket, a global news intelligence service for advisors, private equity firms and corporates. Yiqing is leading a team of dedicated journalists across mainland China to cover PE/VC fundraising, M&A deals, PE buyouts and China cross-border M&A intelligence. Yiqing has been an investigative M&A reporter and researcher since 2009, writing industry news ranging from healthcare, new energy and financial service, etc. Yiqing achieved her master degree of multilingual multicultural studies from New York University.
As the Managing Editor in China, Lisha Zhou oversees all the products in China with main focus on PaRR and Dealreporter. She also takes care of all the Shanghai office administrative issues as the registered Bureau Chief of Shanghai Representative Office under the Mergermarket Consulting Limited. Joined the company in September 2005, she developed in-depth regulatory coverage of cross-border M&A transactions in China for mm, DR and PaRR. In recent years, she led the PaRR China team and built up profound content of antitrust investigations, anti-bribery issues and intellectual property related developments in China.